NIH/National Institute of Allergy and Infectious Diseases

Diseases, Conditions, Syndromes

Newly described human antibody prevents malaria in mice

Scientists have discovered a human antibody that protected mice from infection with the deadliest malaria parasite, Plasmodium falciparum. The research findings provide the basis for future testing in humans to determine ...

Diseases, Conditions, Syndromes

Experimental Ebola vaccines elicit year-long immune response

Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that ...

HIV & AIDS

Three-in-one antibody protects monkeys from HIV-like virus

A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...

Diseases, Conditions, Syndromes

Modified experimental vaccine protects monkeys from deadly malaria

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight ...

Diseases, Conditions, Syndromes

Study of Ebola patient traces disease progression and recovery

Analysis of daily gene activation in a patient with severe Ebola virus disease cared for at the National Institutes of Health (NIH) in 2015 found changes in antiviral and immune response genes that pinpointed key transition ...

page 6 from 40